Market Closed -
Nyse
04:00:02 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
133.5
USD
|
+0.56%
|
|
+4.45%
|
+27.44%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
9,612
|
13,149
|
11,592
|
6,728
|
9,570
|
11,709
|
-
|
-
|
Enterprise Value (EV)
1 |
16,691
|
20,988
|
19,945
|
15,313
|
17,497
|
21,639
|
21,808
|
22,004
|
P/E ratio
|
14.2
x
|
18.6
x
|
12.8
x
|
12.8
x
|
14.1
x
|
15.5
x
|
13.6
x
|
12.2
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.84
x
|
1.14
x
|
1
x
|
0.58
x
|
0.79
x
|
0.93
x
|
0.89
x
|
0.86
x
|
EV / Revenue
|
1.47
x
|
1.82
x
|
1.72
x
|
1.32
x
|
1.44
x
|
1.72
x
|
1.66
x
|
1.61
x
|
EV / EBITDA
|
7
x
|
8.83
x
|
8.05
x
|
7.39
x
|
7.06
x
|
8.43
x
|
8.17
x
|
7.86
x
|
EV / FCF
|
12.8
x
|
16.1
x
|
15.5
x
|
18.7
x
|
11.7
x
|
21.3
x
|
19.1
x
|
15.9
x
|
FCF Yield
|
7.82%
|
6.22%
|
6.46%
|
5.34%
|
8.52%
|
4.69%
|
5.23%
|
6.29%
|
Price to Book
|
4.43
x
|
9.33
x
|
14.6
x
|
9.48
x
|
8.81
x
|
8.52
x
|
7.2
x
|
6
x
|
Nbr of stocks (in thousands)
|
128,112
|
112,000
|
101,900
|
90,104
|
91,348
|
87,703
|
-
|
-
|
Reference price
2 |
75.03
|
117.4
|
113.8
|
74.67
|
104.8
|
133.5
|
133.5
|
133.5
|
Announcement Date
|
2/10/20
|
2/11/21
|
2/10/22
|
2/22/23
|
2/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
11,388
|
11,551
|
11,619
|
11,610
|
12,140
|
12,567
|
13,110
|
13,669
|
EBITDA
1 |
2,383
|
2,376
|
2,478
|
2,072
|
2,479
|
2,566
|
2,669
|
2,799
|
EBIT
1 |
1,768
|
1,746
|
1,797
|
1,339
|
1,734
|
1,883
|
1,986
|
2,098
|
Operating Margin
|
15.53%
|
15.12%
|
15.47%
|
11.53%
|
14.28%
|
14.99%
|
15.15%
|
15.35%
|
Earnings before Tax (EBT)
1 |
1,195
|
1,318
|
1,518
|
966.3
|
1,177
|
1,212
|
1,302
|
1,684
|
Net income
1 |
811
|
773.6
|
978.4
|
560.4
|
691.5
|
758.5
|
798.3
|
820.7
|
Net margin
|
7.12%
|
6.7%
|
8.42%
|
4.83%
|
5.7%
|
6.04%
|
6.09%
|
6%
|
EPS
2 |
5.270
|
6.310
|
8.900
|
5.850
|
7.420
|
8.638
|
9.812
|
10.94
|
Free Cash Flow
1 |
1,306
|
1,304
|
1,289
|
817
|
1,491
|
1,015
|
1,141
|
1,384
|
FCF margin
|
11.47%
|
11.29%
|
11.1%
|
7.04%
|
12.28%
|
8.08%
|
8.7%
|
10.12%
|
FCF Conversion (EBITDA)
|
54.79%
|
54.89%
|
52.03%
|
39.44%
|
60.14%
|
39.56%
|
42.74%
|
49.44%
|
FCF Conversion (Net income)
|
161.02%
|
168.62%
|
131.78%
|
145.79%
|
215.61%
|
133.82%
|
142.93%
|
168.64%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/10/20
|
2/11/21
|
2/10/22
|
2/22/23
|
2/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
2,938
|
2,944
|
2,818
|
2,927
|
2,949
|
2,917
|
2,873
|
3,000
|
3,121
|
3,146
|
3,021
|
3,129
|
3,193
|
3,214
|
3,142
|
EBITDA
1 |
645.3
|
564.2
|
511.3
|
603.9
|
506.2
|
450.3
|
530.1
|
615.7
|
713.4
|
610.3
|
587.9
|
663.4
|
699.2
|
637.2
|
619.2
|
EBIT
1 |
474.9
|
389.4
|
338.3
|
432.7
|
312
|
256.3
|
352
|
432
|
525
|
415
|
415.1
|
490.8
|
527.9
|
466.6
|
436.1
|
Operating Margin
|
16.16%
|
13.23%
|
12.01%
|
14.78%
|
10.58%
|
8.79%
|
12.25%
|
14.4%
|
16.82%
|
13.19%
|
13.74%
|
15.68%
|
16.53%
|
14.52%
|
13.88%
|
Earnings before Tax (EBT)
|
394.5
|
-
|
262.7
|
348.8
|
207.2
|
147.5
|
214.6
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
259.8
|
187.5
|
162.1
|
224.8
|
105.4
|
68.1
|
115.5
|
178.7
|
246.6
|
150.7
|
188.1
|
212.6
|
238.7
|
182.6
|
-
|
Net margin
|
8.84%
|
6.37%
|
5.75%
|
7.68%
|
3.57%
|
2.33%
|
4.02%
|
5.96%
|
7.9%
|
4.79%
|
6.23%
|
6.79%
|
7.48%
|
5.68%
|
-
|
EPS
2 |
2.360
|
1.790
|
1.610
|
2.300
|
1.130
|
0.7400
|
1.250
|
1.910
|
2.620
|
1.620
|
2.070
|
2.370
|
2.710
|
2.100
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/28/21
|
2/10/22
|
5/5/22
|
8/1/22
|
10/28/22
|
2/22/23
|
5/8/23
|
8/3/23
|
11/7/23
|
2/13/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
7,079
|
7,839
|
8,353
|
8,585
|
7,927
|
9,930
|
10,099
|
10,294
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.97
x
|
3.299
x
|
3.371
x
|
4.144
x
|
3.197
x
|
3.87
x
|
3.783
x
|
3.677
x
|
Free Cash Flow
1 |
1,306
|
1,304
|
1,289
|
817
|
1,491
|
1,015
|
1,141
|
1,384
|
ROE (net income / shareholders' equity)
|
28.4%
|
50.6%
|
93.8%
|
76.4%
|
89.2%
|
66.2%
|
57.6%
|
53.9%
|
ROA (Net income/ Total Assets)
|
4.56%
|
5.19%
|
5.88%
|
3.29%
|
4.67%
|
4.92%
|
5.17%
|
5.3%
|
Assets
1 |
17,796
|
14,908
|
16,638
|
17,023
|
14,822
|
15,412
|
15,455
|
15,491
|
Book Value Per Share
2 |
17.00
|
12.60
|
7.770
|
7.880
|
11.90
|
15.70
|
18.50
|
22.30
|
Cash Flow per Share
2 |
13.50
|
16.10
|
17.60
|
16.30
|
22.10
|
19.40
|
20.30
|
-
|
Capex
1 |
767
|
675
|
641
|
603
|
568
|
637
|
644
|
663
|
Capex / Sales
|
6.73%
|
5.84%
|
5.52%
|
5.19%
|
4.68%
|
5.07%
|
4.91%
|
4.85%
|
Announcement Date
|
2/10/20
|
2/11/21
|
2/10/22
|
2/22/23
|
2/13/24
|
-
|
-
|
-
|
Last Close Price
133.5
USD Average target price
130.6
USD Spread / Average Target -2.19% Consensus |
1st Jan change
|
Capi.
|
---|
| +27.44% | 11.71B | | -14.92% | 84.68B | | +13.30% | 81.12B | | +10.92% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -31.75% | 11.77B | | -1.42% | 11.72B | | -3.97% | 11.66B |
Other Healthcare Facilities & Services
|